Koninklijke DSM NV
AEX:DSM

Watchlist Manager
Koninklijke DSM NV Logo
Koninklijke DSM NV
AEX:DSM
Watchlist
Price: 114.05 EUR
Market Cap: €568.6m

Multiples-Based Value

There is not enough data to reliably calculate the multiples-based value of DSM.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DSM Multiples-Based Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

DSM Competitors Multiples
Koninklijke DSM NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
Koninklijke DSM NV
AEX:DSM
568.6m EUR 0.1 0.3 1 1
US
Sherwin-Williams Co
NYSE:SHW
79.2B USD 3.4 30.8 20 23.6
US
Ecolab Inc
NYSE:ECL
74.5B USD 4.6 35.9 20.9 27.9
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.8T JPY 4.5 23.7 11.5 16
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY 1 10.5 5.8 7.1
CN
Wanhua Chemical Group Co Ltd
SSE:600309
248B CNY 1.4 22.4 19.6 19.6
CH
Givaudan SA
SIX:GIVN
24.5B CHF 3.3 22.8 16.1 20.4
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
US
PPG Industries Inc
NYSE:PPG
23.5B USD 1.5 14.9 10.4 12.9
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.2T INR 6.1 55.5 33.3 40.9
CH
Sika AG
F:SIKA
19.9B EUR 1.6 17.3 10.2 14.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NL
Koninklijke DSM NV
AEX:DSM
Average EV/EBITDA: 16.2
1
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
20
9%
2.2
US
Ecolab Inc
NYSE:ECL
20.9
10%
2.1
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.5
4%
2.9
JP
Y
Yasuhara Chemical Co Ltd
TSE:4957
5.8
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
19.6
34%
0.6
CH
Givaudan SA
SIX:GIVN
16.1
6%
2.7
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
US
PPG Industries Inc
NYSE:PPG
10.4
7%
1.5
IN
Asian Paints Ltd
NSE:ASIANPAINT
33.3
10%
3.3
CH
Sika AG
F:SIKA
10.2
8%
1.3
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett